Lynn Kirkpatrick

2022

In 2022, Lynn Kirkpatrick earned a total compensation of $622.6K as Chief Executive Officer at Ensysce Biosciences, a 116% increase compared to previous year.

Compensation breakdown

Option Awards$214,914
Salary$392,500
Other$15,195
Total$622,609

Kirkpatrick received $392.5K in salary, accounting for 63% of the total pay in 2022.

Kirkpatrick also received $214.9K in option awards and $15.2K in other compensation.

Rankings

In 2022, Lynn Kirkpatrick's compensation ranked 3,994th out of 5,753 executives tracked by ExecPay. In other words, Kirkpatrick earned more than 30.6% of executives.

ClassificationRankingPercentile
All
3,994
out of 5,753
31st
Division
Manufacturing
2,260
out of 3,133
28th
Major group
Chemicals And Allied Products
1,094
out of 1,419
23rd
Industry group
Drugs
1,027
out of 1,320
22nd
Industry
Pharmaceutical Preparations
751
out of 966
22nd
Source: SEC filing on July 13, 2023.

Kirkpatrick's colleagues

We found three more compensation records of executives who worked with Lynn Kirkpatrick at Ensysce Biosciences in 2022.

2022

David Humphrey

Ensysce Biosciences

Chief Financial Officer

2022

Dave Humphrey

Ensysce Biosciences

Chief Financial Officer

2022

Geoff Birkett

Ensysce Biosciences

Chief Commercial Officer

News

You may also like